Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors

In this informative webinar, we’ll explore the role of IDH inhibitors in brain tumor care, including what they are and how they impact diagnosis and treatment decisions. Attendees will learn about the latest advancements in IDH-targeted therapies, including the newly FDA-approved treatment, vorasidenib. Whether you’re a patient, caregiver, or advocate, this session will provide valuable insights into how these therapies are shaping personalized brain tumor treatment options and improving outcomes.

In this Webinar, you will:

• Understand what IDH inhibitors are and how they are diagnosed
• Learn about how IDH inhibitors influence treatment decisions
• Recognize the role of IDH inhibitors in treatment advancements and patient outcomes

For more information, resources or support, call (800) 886-2282 or email info@abta.org.

This webinar will have Spanish subtitles available.
Este seminario de web tendrá subtítulos en español.